Morgan Stanley Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst Aisyah Noor maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, setting a price target of €32.00. This follows a similar Sell rating from Bank of America Securities's Anna Ractliffe issued today. In contrast, Citi maintained a Hold rating on the stock on July 17.
Morgan Stanley analyst Aisyah Noor maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €32.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Noor is a 3-star analyst with an average return of 2.8% and a 43.10% success rate.
In addition to Morgan Stanley, Fresenius Medical Care AG & Co. KGaA also received a Sell from Bank of America Securities’s Anna Ractliffe in a report issued today. However, on July 17, Citi maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).